Home
>
National Drug Code (NDC)
>
Betaseron
Betaseron - 50419-523-35 - (interferon beta-1b)
Drug Information of Betaseron
| Product NDC: | 50419-523 |
| Proprietary Name: | Betaseron |
| Non Proprietary Name: | interferon beta-1b |
| Active Ingredient(s): | & nbsp; interferon beta-1b |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Betaseron
| Product NDC: | 50419-523 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103471 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090709 |
Package Information of Betaseron
| Package NDC: | 50419-523-35 |
| Package Description: | 14 TRAY in 1 BOX (50419-523-35) > 1 KIT in 1 TRAY * 1 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE |
NDC Information of Betaseron
| NDC Code | 50419-523-35 |
| Proprietary Name | Betaseron |
| Package Description | 14 TRAY in 1 BOX (50419-523-35) > 1 KIT in 1 TRAY * 1 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE |
| Product NDC | 50419-523 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | interferon beta-1b |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20090709 |
| Marketing Category Name | BLA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
